Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 12 studies | 22% ± 4% | |
fibroblast | 5 studies | 21% ± 2% | |
epithelial cell | 5 studies | 33% ± 15% | |
B cell | 4 studies | 20% ± 3% | |
natural killer cell | 3 studies | 18% ± 1% | |
GABAergic neuron | 3 studies | 34% ± 1% | |
glutamatergic neuron | 3 studies | 41% ± 4% | |
oligodendrocyte | 3 studies | 18% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2690.50 | 1445 / 1445 | 100% | 22.54 | 183 / 183 |
lung | 100% | 2923.81 | 578 / 578 | 100% | 16.16 | 1155 / 1155 |
prostate | 100% | 2605.49 | 245 / 245 | 100% | 12.52 | 502 / 502 |
breast | 100% | 3017.72 | 459 / 459 | 100% | 17.92 | 1116 / 1118 |
bladder | 100% | 2813.24 | 21 / 21 | 100% | 16.54 | 503 / 504 |
thymus | 100% | 2923.87 | 653 / 653 | 100% | 14.96 | 603 / 605 |
uterus | 100% | 2895.66 | 170 / 170 | 100% | 16.80 | 457 / 459 |
stomach | 100% | 2078.24 | 359 / 359 | 99% | 19.65 | 284 / 286 |
brain | 99% | 1813.30 | 2620 / 2642 | 100% | 15.14 | 705 / 705 |
intestine | 100% | 2526.10 | 966 / 966 | 99% | 19.24 | 522 / 527 |
ovary | 100% | 3114.78 | 180 / 180 | 99% | 9.02 | 424 / 430 |
kidney | 100% | 1670.96 | 89 / 89 | 98% | 12.48 | 880 / 901 |
pancreas | 98% | 1338.65 | 323 / 328 | 99% | 13.21 | 176 / 178 |
skin | 100% | 3346.36 | 1809 / 1809 | 95% | 18.37 | 448 / 472 |
adrenal gland | 100% | 2171.44 | 258 / 258 | 94% | 9.52 | 217 / 230 |
liver | 100% | 1535.13 | 226 / 226 | 90% | 6.70 | 366 / 406 |
adipose | 100% | 3122.82 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2969.83 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 16.07 | 29 / 29 |
spleen | 100% | 2812.28 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 14.92 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.57 | 1 / 1 |
muscle | 100% | 1684.10 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 1516.24 | 837 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 79% | 7.40 | 63 / 80 |
peripheral blood | 69% | 2039.25 | 644 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006396 | Biological process | RNA processing |
GO_0071031 | Biological process | nuclear mRNA surveillance of mRNA 3'-end processing |
GO_0006401 | Biological process | RNA catabolic process |
GO_0016075 | Biological process | rRNA catabolic process |
GO_0071034 | Biological process | CUT catabolic process |
GO_0006364 | Biological process | rRNA processing |
GO_0005730 | Cellular component | nucleolus |
GO_0000178 | Cellular component | exosome (RNase complex) |
GO_0016020 | Cellular component | membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000177 | Cellular component | cytoplasmic exosome (RNase complex) |
GO_0005829 | Cellular component | cytosol |
GO_0000176 | Cellular component | nuclear exosome (RNase complex) |
GO_0005634 | Cellular component | nucleus |
GO_0005085 | Molecular function | guanyl-nucleotide exchange factor activity |
GO_0004519 | Molecular function | endonuclease activity |
GO_0003723 | Molecular function | RNA binding |
GO_0000175 | Molecular function | 3'-5'-RNA exonuclease activity |
GO_0005515 | Molecular function | protein binding |
Gene name | DIS3 |
Protein name | DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease DIS3 protein Exosome complex exonuclease RRP44 (EC 3.1.13.-) (EC 3.1.26.-) (Protein DIS3 homolog) (Ribosomal RNA-processing protein 44) DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease (KIAA1008, isoform CRA_c) |
Synonyms | hCG_32200 KIAA1008 RRP44 |
Description | FUNCTION: Putative catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. DIS3 has both 3'-5' exonuclease and endonuclease activities. . |
Accessions | ENST00000377767.9 [Q9Y2L1-1] ENST00000490646.1 F2Z2C0 G3V1J5 Q49AG4 ENST00000377780.8 [Q9Y2L1-2] ENST00000545453.5 Q9Y2L1 |